NMN zwitterion/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on LDL cholesterol
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“Regarding lipid indicators, NMN supplementation had no significant effect on HDL-C, LDL-C, total cholesterol, or triglycerides.”
Quoted verbatim from Safety and Metabolism-Related Outcomes of Oral Nicotinamide Mononucleotide Supplementation in Adults: A Systematic Review and Meta-Analysis.. - Study
- meta-analysis
- Dose
- 250-2000 mg/day oral across included trials
- Population
- Adults in randomized controlled trials of oral NMN or NMN-related preparations (including MIB-626) against placebo or no-NMN controls; random-effects pooled analysis
Safety and Metabolism-Related Outcomes of Oral Nicotinamide Mononucleotide Supplementation in Adults: A Systematic Review and Meta-Analysis.2026PMID:42514320Permalink
Keep reading
- Everything the graph holds on NMN zwitterion
- Every compound studied against LDL cholesterol
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PPQPWH1VDTYYTB0GGGNYBM